Author:
Hu Yan,Hou Anji,Zhang Hongwei,Zhou Wei,Shen Xiaoyan,Huang Yanli,Zhou Li
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Scagliotti G. Optimizing chemotherapy for patients with advanced nonsmall cell lung cancer. J Thorac Oncol, 2007, 2(Suppl 2): S86–91.
2. Devlin JG, Langer CJ. Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature. Clin Lung Cancer, 2007, 8: 319–326.
3. Sekine I, Nokihara H, Sumi M, et al. Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer. J Thorac Oncol, 2006, 1: 810–815.
4. Luo ZG, Chang JH, Yu H, et al. Analysis of chemotherapy with 5-Fu by continous intravenous infusion and cisplatin in head and neck advanced cancer. Chin Oncol (Chinese), 2007, 17: 716–718.
5. Huang JC, Li Y, Hu P, et al. Clinical study of traditional Chinese medical herbs on portal embolus of 40 hepetacellular carcinoma patients. Oncol Prog (Chinese), 2007, 5: 598–601.